 |
Recombinant AAV9 expressing human alpha-N-acetylglucosaminidase |
|---|---|
| Trade Name | |
| Orphan Indication | Mucopolysaccharidosis III-B (Sanfilippo Syndrome Type B) |
| USA Market Approval | USA |
| USA Designation Date | 2014-04-30 00:00:00 |
| Sponsor | Abeona Therapeutics LLC;10000 Cedar Avenue;Cleveland, Ohio, 44106 |
